Timely Administration of IV Magnesium Sulfate in Patients With a Moderate Asthma Exacerbation
Recruiting · NCT06137040 · Interventional (participants receive a specific treatment) · Lead sponsor: University of Oklahoma
View the official record on ClinicalTrials.gov →Interventions studied
Magnesium Sulfate within the first hourNo Magnesium sulfate within the first hour
What this trial is about
This study aims to identify whether early administration of magnesium sulfate in moderate asthma exacerbations can potentially avoid admission, decrease length of stay in the emergency department (ED), decrease length of stay (LOS) in the general hospital floor vs pediatric intensive care unit (PICU), and decrease the need for respiratory support.
Who can take part
Age range
5 Years to 17 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Early Phase 1
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Ages 5-17 years old
- Presents to the ED with a respiratory score in the "Moderate" range (6
- Parent(s)/Caregiver(s) speak English
Exclusion criteria
- Patients with chronic medical conditions including chronic pulmonary disease (other than asthma), cerebral palsy, congenital heart disease, tracheostomy dependent, myasthenia gravis patients
- Patients who are pregnant
- Parent(s)/Caregiver(s) do not speak English
Where it is running
1 location listed across 1 US state.
- Oklahoma Children's Hospital - Oklahoma City, Oklahoma, United States